Real‐world experience of adjuvant immunotherapy for stages III–IV melanoma: A monocentric observational study by Manon Blaise, Eric Fontas, Barbara Seitz‐Polski, Laura Troin, Alexandra Picard, Perrine Rousset, Elodie Long‐Mira, Micheline Razzouk‐Cadet, Madleen Chassang, Thierry Passeron, Henri Montaudié

Get full text

Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201) by Federica Morano, Celeste Lebbe, Mark Cornfeld, Shailender Bhatia, Melissa Burgess, Giovanni Grignani, Piotr Rutkowski, Francesca Spada, Michele Guida, Chuan Tian, Caroline Gaudy-Marqueste, Roberta Depenni, Henri Montaudié, Jennifer Pulini, Francesco Spagnolo, Cecilia C S Yeung

Get full text

Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study by Alizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, Michel D’Incan, Gaëlle Quereux, Emmanuella Guenova, Marie Perier-Muzet, Stephane Dalle, Florent Grange, Manuelle-Anne Viguier, Caroline Ram-Wolff, Laurence Feldmeyer, Helmut Beltraminelli, Nathalie Bonnet, Florent Amatore, Eve Maubec, Nathalie Franck, Laurent Machet, François Chasset, Florence Brunet-Possenti, Jean-David Bouaziz, Maxime Battistella, Marie Donzel, Anne Pham-Ledard, Claudia Bejar, Hélène Moins-Teisserenc, Samia Mourah, Philippe Saiag, Ewa Hainaut, Catherine Michel, Guido Bens, Henri Adamski, François Aubin, Serge Boulinguez, Pascal Joly, Billal Tedbirt, Isabelle Templier, Laura Troin, Henri Montaudié, Saskia Ingen-Housz-Oro, Sarah Faiz, Laurent Mortier, Gabor Dobos, Martine Bagot, Matthieu Resche-Rigon, Claire Montlahuc, Arnaud Serret-Larmande, Adèle de Masson

Get full text